SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-011388
Filing Date
2020-10-06
Accepted
2020-10-06 16:43:50
Documents
14
Period of Report
2020-10-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20201003x8k.htm   iXBRL 8-K 61844
2 EX-99.1 mgtx-20201003xex99d1.htm EX-99.1 38462
3 GRAPHIC mgtx-20201003xex99d1001.jpg GRAPHIC 2898
  Complete submission text file 0001558370-20-011388.txt   243476

Data Files

Seq Description Document Type Size
4 EX-101.SCH mgtx-20201003.xsd EX-101.SCH 3022
5 EX-101.LAB mgtx-20201003_lab.xml EX-101.LAB 16735
6 EX-101.PRE mgtx-20201003_pre.xml EX-101.PRE 10603
7 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20201003x8k_htm.xml XML 5052
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 201227204
SIC: 2836 Biological Products, (No Diagnostic Substances)